Cita APA

ZHU, Y., MAO, C., WU, J., LI, S., MA, R., CAO, H., . . . TANG, J. (2014). Improved ataxia telangiectasia mutated kinase inhibitor KU60019 provides a promising treatment strategy for non-invasive breast cancer. D.A. Spandidos.

Citación estilo Chicago

ZHU, YING, CHANGFEI MAO, JIANZHONG WU, SHUCHUN LI, RONG MA, HAIXIA CAO, MINGHUA JI, CHANGWEN JING, y JINHAI TANG. Improved Ataxia Telangiectasia Mutated Kinase Inhibitor KU60019 Provides a Promising Treatment Strategy for Non-invasive Breast Cancer. D.A. Spandidos, 2014.

Cita MLA

ZHU, YING, et al. Improved Ataxia Telangiectasia Mutated Kinase Inhibitor KU60019 Provides a Promising Treatment Strategy for Non-invasive Breast Cancer. D.A. Spandidos, 2014.